H-L-Cys(Bzl)-OMe*HCl

H-L-Cys(Bzl)-OMe*HCl is an L-cysteine-derived amino acid ester hydrochloride in which the thiol side chain is protected as a benzyl thioether (Cys(Bzl)) and the carboxyl group is present as a methyl ester hydrochloride salt. The molecule retains a stereogenic center at the α-carbon consistent with L-configuration, while the benzyl-protected sulfur and the esterified carboxyl modulate nucleophilicity and coupling behavior during peptide assembly. The hydrochloride counterion increases handling stability and can influence solubility in polar organic media used for protected amino acid chemistry. The benzyl thioether and methyl ester functional group pattern supports controlled deprotection and subsequent conversion to free thiols, amide linkages, or further side-chain functionalization for peptide science and synthetic intermediate preparation.

1. Protected Amino Acid Synthesis

H-L-Cys(Bzl)-OMe*HCl is applied in protected amino acid synthesis and downstream peptide building-block preparation where orthogonal protection is required for cysteine chemistry. The benzyl thioether on the side chain suppresses thiol reactivity during ester activation and amide bond formation, while the methyl ester enables C-terminal activation strategies compatible with peptide coupling workflows. Hydrochloride salt formation supports practical handling as a chiral amino acid ester intermediate, including controlled conversion to activated derivatives prior to coupling. Resulting derivatives can be carried into peptide coupling sequences and then transformed into thiol-bearing cysteine residues after selective thioether deprotection, supporting stereochemically defined peptide construction.

2. Peptide Synthesis

H-L-Cys(Bzl)-OMe*HCl serves as a cysteine-containing peptide synthesis component for assembling thioether-protected sequences that require stable sulfur protection during chain elongation. The α-amino functionality and the esterified carboxyl group provide a defined reactive pattern for incorporation into peptide coupling chemistry, while the benzyl-protected side chain helps prevent disulfide scrambling or unwanted thioalkylation under typical coupling conditions. L-stereochemistry at the α-carbon supports the fidelity of chiral peptide frameworks and can be maintained through iterative assembly. After peptide assembly, benzyl thioether removal can generate free thiols for native cysteine presentation, disulfide formation control, or further derivatization to generate cysteine-modified peptide analogs.

3. Side-Chain Functionalization

H-L-Cys(Bzl)-OMe*HCl is utilized in side-chain functionalization workflows that convert protected cysteine motifs into thiol-reactive intermediates for chemical biology and materials-oriented conjugation chemistry. The benzyl thioether functions as a removable sulfur protecting group, enabling stepwise generation of reactive thiol species at a chosen stage of synthesis. The methyl ester can be transformed into amide or other carboxyl-derived linkages, allowing incorporation into linker systems, thioether-to-thiol conversion sequences, or preparation of cysteine-based handles for subsequent functional group installation. Downstream products can include thiol-containing amino acid derivatives, cysteine-functional linkers, and peptide conjugation precursors used to build structured molecular scaffolds.

4. Bioconjugation Chemistry

H-L-Cys(Bzl)-OMe*HCl supports bioconjugation chemistry by providing a cysteine-derived scaffold that can be converted into thiol-bearing conjugation reagents with controlled timing of deprotection. The protected sulfur reduces premature reactivity during synthesis of conjugate precursors, while L-configuration helps maintain stereochemical identity of cysteine motifs used in protein labeling and peptide-based targeting constructs. The ester-to-amide or related carboxyl conversion enables attachment of the cysteine unit to carrier molecules or linkers that interface with biomolecules. Generated thiol-containing intermediates can then participate in thiol-specific coupling chemistries to produce defined conjugates for biomolecule modification and analytical labeling strategies.

5. Pharmaceutical Intermediate Preparation

H-L-Cys(Bzl)-OMe*HCl is suitable for pharmaceutical intermediate preparation in fine chemical synthesis where protected cysteine building blocks are required for controlled functional group choreography. The benzyl thioether and methyl ester combination provides a protected amino acid derivative format that can be carried through multi-step synthesis with reduced risk of thiol side reactions. The hydrochloride salt form can assist in consistent handling during intermediate transformations that lead to amide-forming segments and cysteine-containing fragments for peptidomimetic or peptide-like structures. The resulting intermediates can be further processed into thiol-enabled derivatives, enabling downstream assembly of sulfur-containing motifs relevant to industrial-scale synthesis of amino acid-derived compounds.

1. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

2. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

3. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

4. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

5. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation